Expression Changes of Mitogen-activated Protein Kinase Phosphatase-1 (MKP-1) in Myocardium of Streptozotocin-Induced Diabetic Rats

Abstract

MAP Kinase Phosphatase-1 (MKP-1) is a dual specific phosphatase selective for MAP kinases, and was believed to implicate in the development of cardiac hypertrophy. However, whether MKP-1 is involved in the pathogenesis of diabetic cardiomyopathy is still unknown. We employed streptozotocin (STZ)-induced diabetic Sprague-Dawley rats to study the alteration of the MKP-1 expressions in the left ventricular myocardium in diabetic and normal groups by immunohistochemistry and real-time quantitative reverse transcription-polymerase chain reaction. The weight, blood sugar and urine sugar were measured before and after model induction in both control and diabetic groups. Changes of heart ultrastructure were analyzed by using transmission electron microscopy. The data of weight, blood sugar and urine sugar indicated no significant difference between the two groups before animal model induction. Eight weeks after the induction of diabetes, the differences between the control and the diabetic groups in weight, blood sugar and urine sugar were significant (P<0.01). When compared with control, diabetic myocardium ultrastructural changes included myofibrillar disarrangements, mitochondria disruption, and increase in nuclear membrane invaginations. A significant decrease of MKP-1 expression was observed in the diabetic rats’ myocardium (P<0.01). Our study provides experimental evidences that hyperglycemia could damage myocardial ultrastructure. Moreover, we provided first evidence that down-regulation of cardioprotective peptide MKP-1, the MAPK pathway negative regulator, in myocardium of streptozotocin-induced diabetic rats, which may contribute to the deterioration of cardiac function and lead to diabetic cardiomyopathy.

Key words

Diabetic cardiomyopathy - mitogen-activated protein kinase phosphatase-1 - real-time quantitative reverse transcription-polymerase chain reaction - transmission electron microscopy

References

• 1 Alessi DR, Smythe C, Keyse SM. The human Cl100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates map kinase and suppresses its activation by oncogenic ras in xenopus oocyte extracts.  Oncogene. 1993;  8 2015-2020
• 2 Brondello JM, Mckenzie FR, Sun H, Tonks NK, Pouyssegur J. Constitutive map kinase phosphatase (Mkp-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts.  Oncogene. 1995;  10 1895-1904
• 3 Duff JL, Monia BP, Berk BC. Mitogen-activated protein (Map) kinase is regulated by the map kinase phosphatase (Mkp-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides.  J Biol Chem. 1995;  270 7161-7166
• 4 Fuller SJ, Davies EL, Gillespie-Brown J, Sun H, Tonks NK. Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes.  Biochem J. 1997;  323 ((Pt 2)) 313-319
• 5 Garcia MJ, Mcnamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the framingham population. Sixteen year follow-up study.  Diabetes. 1974;  23 105-111
• 6 Haider B, Yeh CK, Thomas G, Oldewurtel HA, Lyons MM, Regan TJ. Influence of diabetes on the myocardium and coronary arteries of rhesus monkey fed an atherogenic diet.  Circ Res. 1981;  49 1278-1288
• 7 Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy.  Jama. 1974;  229 1749-1754
• 8 Komuro I, Kudo S, Yamazaki T, Zou Y, Shiojima I, Yazaki Y. Mechanical stretch activates the stress-activated protein kinases in cardiac myocytes.  Faseb J. 1996;  10 631-636
• 9 Liu Y, Gorospe M, Yang C, Holbrook NJ. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of C-Jun N-terminal kinase activity and Ap-1-dependent gene activation.  J Biol Chem. 1995;  270 8377-8380
• 10 Nemoto S, Sheng Z, Lin A. Opposing effects of Jun kinase and P38 Mitogen-activated protein kinases on cardiomyocyte hypertrophy.  Mol Cell Biol. 1998;  18 3518-3526
• 11 Ouwens DM, Boer C, Fodor M, Galan P De, Heine RJ, Maassen JA, Diamant M. Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats.  Diabetologia. 2005;  48 1229-1237
• 12 Sun H, Charles CH, Lau LF, Tonks NK. Mkp-1 (3ch134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates map kinase in vivo.  Cell. 1993;  75 487-493
• 13 Tomlinson KC, Gardiner SM, Hebden RA, Bennett T. Functional consequences of Streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system.  Pharmacol Rev. 1992;  44 103-150
• 14 Wang Y, Su B, Sah VP, Brown JH, Han J, Chien KR. Cardiac hypertrophy induced by Mitogen-activated protein kinase kinase 7, A specific activator for C-Jun Nh2-terminal kinase in ventricular muscle cells.  J Biol Chem. 1998;  273 5423-5426
• 15 Xiaoming Z, Xi Z, Fang S, Jilin Z. Specific changes of somatostatin MRNA expression in the frontal cortex and hippocampus of diabetic rats.  J Anat. 2004;  204 221-225
• 16 Xu H, Dembski M, Yang Q, Yang D, Moriarty A, Tayber O, Chen H, Kapeller R, Tartaglia LA. Dual specificity Mitogen-activated protein (Map) kinase phosphatase-4 plays a potential role in insulin resistance.  J Biol Chem. 2003;  278 30187-30192
• 17 Xu H, Yang Q, Shen M, Huang X, Dembski M, Gimeno R, Tartaglia LA, Kapeller R, Wu Z. Dual specificity Mapk phosphatase 3 activates Pepck gene transcription and increases gluconeogenesis in rat hepatoma cells.  J Biol Chem. 2005;  280 36013-36018
• 18 Zhang XM, Shen F, Xv ZY, Yan ZY, Han S. Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of Stz-induced rats.  Int J Cardiol. 2005;  105 192-197
• 19 Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment.  Diabetes Metab Rev. 1994;  10 339-383

1 Grant support: Natural Science Foundation of Zhejiang Province (No. Y204036)
Health bureau Foundation of Zhejiang Province (No. 2006A083)

Correspondence